Portfolio includes 25 modern logistics assets concentrated in major U.S. distribution hubs Since 2020, EQT Real Estate has assembled and actively managed the portfolio, leveraging
Mortgage Rates Today, November 25, 2025: 30-Year Rates Climb to 6.34%
Factors influencing current mortgage rates Today’s mortgage rates are influenced by economic and market conditions, as well as personal factors. The rate you’re quoted
Homebuyers are entering into riskier loans with the hope mortgage rates are going to eventually fall. Will the gamble be worth it?
Danielle Antosz November 25, 2025 at 8:30 AM Moving, lesbian and couple with dog in new home, boxes and smile in real estate together.
New Novo drug delivers significant weight-loss benefits in diabetes trial
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be
CleanSpark (CLSK) Rockets 18% on Bullish Analyst Coverage
We recently published 10 Stocks Stealing Wall Street Spotlight. CleanSpark, Inc. (NASDAQ:CLSK) is one of the best-performing stocks on Monday. CleanSpark snapped a three-day
RBC Capital Bullish on Uber Technologies (UBER), Cites AV Tech Development
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a
Wall Street Bullish on Alphabet Inc. (GOOGL) Since the Release of Gemini 3
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a
Stock Market Live November 25: S&P 500 (SPY) Little Changed in Short Holiday Week
Live Updates Get The Best Google Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Google, market updates, and
Adolescence lasts into 30s – new study shows four pivotal ages for your brain
The brain goes through five distinct phases in life, with key turning points at ages nine, 32, 66 and 83, scientists have revealed. Around
Orforglipron pill shows great weight-loss results in new trial
Orforglipron pill shows great weight-loss results in new trial New clinical trial results revealed that orforglipron could become the first GLP-1 weight-loss drug accessible